Service description and background. 1.1. Patients and the general public access community pharmacies for self-care advice and to purchase over the counter medicines. It is however difficult sometimes for patients to know when it might be more appropriate to access GP advice. It is estimated that 6% of all GP consultations could be safely transferred to a community xxxxxxxx0 (20.4 million appointments per year) and there is good evidence that the advice provided by community pharmacists as part of a consultation about symptoms of minor illness will result in the same outcome as if the patient went to see their GP or attended an Emergency Department.3
1.2. As part of the Pharmacy Integration Fund programme of work to integrate community pharmacy into local NHS urgent care pathways, a new approach is being taken to create a digital process for sending a “referral” to a community pharmacist instead of booking a GP appointment for a low acuity minor illness assessment.
1.3. The term “referral” is used to describe the process where practice staff advise patients that they can attend a local community pharmacy for a consultation with a pharmacist and that personal data about them will be transferred to the pharmacy. The GP practice may use a streaming process or other local protocol to identify patients to be referred dependent on the symptoms declared by the patient. In some instances, this may make use of clinical triage or a referral following an online assessment process. The GP practice is responsible for ensuring the robustness of their chosen method of “referral” to the pharmacy (See Annex A for definitions).
1.4. The NHS England GP CPCS will commence from 1st April 2020 to 31st October 2020
1.5. The GP Community Pharmacist Consultation Service (GP CPCS) will be commissioned as a Local Enhanced Service under the terms of the Community Pharmacy Contractual Framework, with the aim of ensuring that patients have access to care close to home and with a self-care emphasis.
1.6. An electronic transfer of data to support the referral will be sent from the General Practice to a local community pharmacy. Across practices in England there are now GP reception teams that work with care navigators to support the process of booking patients to see the most appropriate member of the multidisciplinary team. Only patients who have been referred from their GP practice are eligible to receive advice and treatment 2 xxxxx://xxx.xxxxxxx.xxx.xx/gp/gpfv/workload/releasing-pressure/ 3 xxxxx://xxxxxxx.xxx.xxx/conte...
Service description and background. This service is commissioned as a local enhanced service under the powers given to NHS England by The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 paragraph 14 (1) (h) and (o). Community Pharmacists will contribute to the reduction of prescribed unwanted medicines, which currently are wasted. This service will be undertaken at the point of dispensing. This will help to prevent patient’s stockpiling of prescribed medicines and reduce inefficiencies in prescribing on FP10s. The service will inform GP repeat prescribing processes thus contributing to improved patient outcomes through harm reduction, reduced hospital admissions, and increased medicine concordance. It is expected that the service will encourage Pharmacists to carry out Medicine Use Reviews (MUR) with patients who they have identified as having issues with their prescribed medicines or processes around ordering repeat medicines. The object of this scheme is to reduce the burden of waste medicines, which has far reaching implications both financially and in terms of harm and health outcomes for patients: To reduce the number of unwanted medicines dispensed and therefore wasted, by not dispensing items not required by the patient. To notify the prescriber when an item prescribed has not been dispensed. To promote, support and encourage good repeat / prescribing practices with patients and GP practices. To highlight under usage of medicines to the prescriber. To inform the prescriber whether the continued supply or non-supply of items would be considered clinically significant. To highlight prescribing inefficiencies to the prescriber. To reduce unnecessary prescribing costs.
Service description and background. This service is commissioned as a local enhanced service under the powers given to NHS England by The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 paragraph 14 (1) (j). This service is available to all patients who are exempt from paying prescription charges. The patients must be registered with a GP practice located within the Clinical Commissioning Group. Patients are at liberty to refuse this service. Patients can receive advice and/or treatment under the Minor Ailments Scheme on the conditions listed in Appendix 6. Patients who pay for their prescriptions should be referred to a pharmacy for advice and to purchase over the counter medicines in the usual way. This service is a "stepping stone" towards the "Self-Care" approach to healthcare. Only Community Pharmacies who are committed to making staff available to provide the service and who have completed the necessary training for the conditions listed in Appendix 6 will be included in the Minor Ailments Scheme.
Service description and background.
1.1. This pilot will specifically evaluate the implementation by community pharmacy of direct referrals to secondary care diagnostics/Rapid Diagnostic Service (RDS) triage teams for people with suspected cancer signs and symptoms. The pilot will initially focus on testing safety and technical feasibility with a small number of Community Pharmacies before expanding to full pilot roll out and data collection to evaluate the benefits of direct referrals from Community Pharmacy for people presenting with suspected cancer symptoms.
1.2. Developing a direct referral service from community pharmacy to secondary care diagnostics/RDS triage teams for people with suspected cancer symptoms has the potential to improve patient outcomes and reduce health inequalities. It is hoped it will support the NHS Long Term Plan’s aims of 75% of cancer patients being diagnosed at Stage 1 or 2.
1.3. NHS England (NHSE) is commissioning this pilot as a Local Pharmacy Enhanced Service.
1.4. The key objectives of this pilot are: • To test the feasibility and acceptability of referral routes into secondary care and diagnostic centres. • To undertake quantitative and qualitative evaluation including patient experience and the experience of community pharmacy, primary and secondary care/RDS teams. • To test a new funding model, which aims to fairly remunerate provision of a quality service.
1.5. The decision to refer will be made during the consultation with the patient in the pharmacy consultation room, so that the appropriate next steps can be organised within a single episode of care.
1.6. Upon the patient’s presentation at the pharmacy, the pharmacist will conduct an appropriate clinical assessment (using the referral criteria outlined in the clinical protocol) in the pharmacy consultation room and record the consultation notes and make the referral (if needed). An online MS Form will be used to capture the consultation.
1.7. The clinical assessment would result in one of three outcomes based on the referral criteria, namely:
a) The individual does not meet the referral criteria
b) The individual meets the criteria for onward investigation in Primary Care
c) The individual meets the referral criteria for referral to secondary care/RDS
1.8. The pharmacist submits a claim for payment for the service.
1.9. An evaluation of the service will be undertaken to facilitate a robust review and financial appraisal for NHS commissioners. The evaluation will examine the role of community pharma...
Service description and background. This service is commissioned as a local enhanced service under the powers given to NHS England by The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 paragraph 14 (1) (i). Community pharmacies can support patients staying in their own homes rather than other care settings by supporting care agencies in the safe administration of medicines and the appropriate recording of the same.
Service description and background. This service is commissioned as a local enhanced service under the powers given to NHS England by The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 paragraph 14 (1) (i). An ‘authorised person’ in this service specification is a person acting under arrangements with the CCG for the purpose of coordinating access to this service. The pharmacy will help support vulnerable people, who require more support than a ‘one off’ adjustment, as covered under the Disability Discrimination Xxx 0000 criteria. The pharmacy will be contacted by an authorised person for professional discussions about the appropriate level or kind of support, if any, required by the person to help them take their medicines as intended. If support is necessary, the authorised person and Pharmacy will agree with the person the appropriate level or kind of support. The pharmacy may provide advice, support and assistance to the person, family member or informal carer with a view to improving the patient’s knowledge and use of their drugs and their compliance, or may need to refer to their GP for further referral to other health and social care professionals where appropriate. The pharmacy will provide the support as described within the Open A ction Plan contained within the Patient file set up by the authorised person.
Service description and background. This service is commissioned as a local enhanced service under the powers given to NHS England by The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 paragraph 14 (1) (u). In an emergency, a pharmacist can supply prescription only medicines (POMs) to a patient (who has previously been prescribed the requested POM) without a prescription at the request of a patient. This emergency supply is not an NHS service and patients may therefore be asked to pay the cost of the medicine. This can lead to some patients seeking supplies or emergency prescriptions from urgent or emergency care providers or placing extra demand on GP appointments. When demand is high it may not be practical to obtain a prescription in a timely way to meet immediate need. The Community Pharmacy Emergency Supply Service allows the emergency supply of a patient’s medicine at NHS expense in order to reduce the number of patients contacting urgent and emergency care providers. This may include both prescription only and other medicines usually obtained on prescription by the patient from their GP. The emergency supply provisions permit the supply of sufficient quantities of most prescription only medicines for up to 30 days treatment, this service specification allows for up to 7 days treatment only. Exceptions apply for inhalers and creams / ointments, where a manufacturer’s pack can be supplied. Schedule 1, 2 or 3 controlled drugs (except phenobarbitone or phenobarbitone sodium for epilepsy) cannot be supplied in an emergency. Quantities of other medicines should be in line with this. During a pandemic situation, a pharmacist may make an emergency supply against a request by a patient’s representative; at all other times the request must be made directly by the patient. The purpose of the Community Pharmacy Emergency Supply Service is to ensure that patients can access an urgent supply of their regular prescription medicines where they are unable to obtain a prescription before they need to take their next dose. The service may be needed because the patient has run out of a medicine, or because they have lost or damaged their medicines, or because they have left home without them. The aim of this service is to relieve pressure on urgent and emergency care services and general practitioner appointments at times of high demand. In an emergency, a pharmacist can supply prescription only medicines (POMs) to a patient (who has previously been prescribed the requ...
Service description and background. The Marketing Spend Management Applications provide Marketers the visibility and process support to enable spending of marketing budgets. These Applications are in the process of being transitioned to a new platform to improve the efficiency and effectiveness of the Brand Marketers. During the transition the Supplier and Buyer organizations will need to continue to provide application and business process support for the legacy Applications. In addition, the Buyer and Supplier organizations will need to deliver the configuration, development, testing, change management and training of the new [ * * * ] application and all interfaces to SAP.
Service description and background. 2.1 The Community Pharmacy Vaccination Service is a further phase of the Vaccine Transformation Programme (VTP) in developing and evaluating alternative options prior to April 2022, when flu vaccination may no longer be part of the General Medical Services (GMS)
Service description and background. 1.1. This service is commissioned as a local enhanced service under the powers given to NHS England by The Pharmaceutical Services (Advanced and Enhanced Services) (England) Directions 2013 paragraph 14 (1) (i).
1.2. An ‘authorised person’ in this service specification is a person acting under arrangements with the service commissioner for the purpose of coordinating access to this service.
1.3. Community pharmacies can help patients to stay in their own homes, rather than other care settings, by supporting them to self-medicate where safe and appropriate.
1.4. Ambulatory patients will be referred to the pharmacy by East Riding of Yorkshire Council Adult Services Assessment Team or Community Support Services team for discussions about the appropriate level or kind of support required by the person to help them take their medicines as intended. The Pharmacy will agree with the person the nature of that support and inform the Adult Services Assessment or Community Support Services teams.
1.5. Housebound patients will be assessed by the corresponding Medication Support Service (Housebound) and potential support discussed and agreed with the pharmacy.
1.6. The pharmacy may provide advice, support and assistance to the person and/or, with the patient’s consent, family member or informal carer with a view to improving the patient’s knowledge and use of their drugs and their compliance. A medicines compliance review, supplemented by a clinical medication review by a practice pharmacist, may be needed to reduce medication burden or otherwise enable the patient to self-medicate. Liaison with the GP or practice pharmacist should take place as an integral part of the assessment
